Small Molecule Anti-tumor Targted Drug Market Insights, Global Outlook and Forecast 2022-2028
Small Molecule Anti-tumor Targted Drug Market Insights, Global Outlook and Forecast 2022-2028
Analysis of the Small Molecule Anti-tumor Targted Drug Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The latest research study released by Market IntelliX evaluates market size and forecasts of Small Molecule Anti-tumor Targted Drug in Global, including the following market information:
Global Small Molecule Anti-tumor Targted Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Small Molecule Anti-tumor Targted Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
EGFR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Small Molecule Anti-tumor Targted Drug include Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Small Molecule Anti-tumor Targted Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Small Molecule Anti-tumor Targted Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Small Molecule Anti-tumor Targted Drug Market Segment Percentages, by Type, 2021 (%)
EGFR
ALK
Bcr-Abl
Others
Global Small Molecule Anti-tumor Targted Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Small Molecule Anti-tumor Targted Drug Market Segment Percentages, by Application, 2021 (%)
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
Global Small Molecule Anti-tumor Targted Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Small Molecule Anti-tumor Targted Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule Anti-tumor Targted Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Small Molecule Anti-tumor Targted Drug revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Small Molecule Anti-tumor Targted Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Anti-tumor Targted Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Anti-tumor Targted Drug Overall Market Size
2.1 Global Small Molecule Anti-tumor Targted Drug Market Size: 2021 VS 2028
2.2 Global Small Molecule Anti-tumor Targted Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule Anti-tumor Targted Drug Players in Global Market
3.2 Top Global Small Molecule Anti-tumor Targted Drug Companies Ranked by Revenue
3.3 Global Small Molecule Anti-tumor Targted Drug Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule Anti-tumor Targted Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Small Molecule Anti-tumor Targted Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule Anti-tumor Targted Drug Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule Anti-tumor Targted Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule Anti-tumor Targted Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Small Molecule Anti-tumor Targted Drug Market Size Markets, 2021 & 2028
4.1.2 EGFR
4.1.3 ALK
4.1.4 Bcr-Abl
4.1.5 Others
4.2 By Type - Global Small Molecule Anti-tumor Targted Drug Revenue & Forecasts
4.2.1 By Type - Global Small Molecule Anti-tumor Targted Drug Revenue, 2017-2022
4.2.2 By Type - Global Small Molecule Anti-tumor Targted Drug Revenue, 2023-2028
4.2.3 By Type - Global Small Molecule Anti-tumor Targted Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Molecule Anti-tumor Targted Drug Market Size, 2021 & 2028
5.1.2 Liver Cancer
5.1.3 Colorectal Cancer
5.1.4 Lung Cancer
5.1.5 Gastric Cancer
5.1.6 Breast Cancer
5.1.7 Esophageal Cancer
5.1.8 Others
5.2 By Application - Global Small Molecule Anti-tumor Targted Drug Revenue & Forecasts
5.2.1 By Application - Global Small Molecule Anti-tumor Targted Drug Revenue, 2017-2022
5.2.2 By Application - Global Small Molecule Anti-tumor Targted Drug Revenue, 2023-2028
5.2.3 By Application - Global Small Molecule Anti-tumor Targted Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Small Molecule Anti-tumor Targted Drug Market Size, 2021 & 2028
6.2 By Region - Global Small Molecule Anti-tumor Targted Drug Revenue & Forecasts
6.2.1 By Region - Global Small Molecule Anti-tumor Targted Drug Revenue, 2017-2022
6.2.2 By Region - Global Small Molecule Anti-tumor Targted Drug Revenue, 2023-2028
6.2.3 By Region - Global Small Molecule Anti-tumor Targted Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Small Molecule Anti-tumor Targted Drug Revenue, 2017-2028
6.3.2 US Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.3.3 Canada Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.3.4 Mexico Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Small Molecule Anti-tumor Targted Drug Revenue, 2017-2028
6.4.2 Germany Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.4.3 France Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.4.4 U.K. Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.4.5 Italy Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.4.6 Russia Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.4.7 Nordic Countries Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.4.8 Benelux Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Small Molecule Anti-tumor Targted Drug Revenue, 2017-2028
6.5.2 China Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.5.3 Japan Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.5.4 South Korea Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.5.5 Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.5.6 India Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Small Molecule Anti-tumor Targted Drug Revenue, 2017-2028
6.6.2 Brazil Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.6.3 Argentina Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Molecule Anti-tumor Targted Drug Revenue, 2017-2028
6.7.2 Turkey Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.7.3 Israel Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
6.7.5 UAE Small Molecule Anti-tumor Targted Drug Market Size, 2017-2028
7 Players Profiles
7.1 Astrazeneca
7.1.1 Astrazeneca Corporate Summary
7.1.2 Astrazeneca Business Overview
7.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.1.4 Astrazeneca Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.1.5 Astrazeneca Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.2.4 Novartis Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Millennium Pharmaceuticals
7.3.1 Millennium Pharmaceuticals Corporate Summary
7.3.2 Millennium Pharmaceuticals Business Overview
7.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.3.4 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.3.5 Millennium Pharmaceuticals Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.4.4 Bayer Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.4.5 Bayer Key News
7.5 Exelixis
7.5.1 Exelixis Corporate Summary
7.5.2 Exelixis Business Overview
7.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.5.4 Exelixis Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.5.5 Exelixis Key News
7.6 Abbvie
7.6.1 Abbvie Corporate Summary
7.6.2 Abbvie Business Overview
7.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.6.4 Abbvie Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.6.5 Abbvie Key News
7.7 Boehringer-Ingelheim
7.7.1 Boehringer-Ingelheim Corporate Summary
7.7.2 Boehringer-Ingelheim Business Overview
7.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.7.4 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.7.5 Boehringer-Ingelheim Key News
7.8 Eisai
7.8.1 Eisai Corporate Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.8.4 Eisai Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.8.5 Eisai Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.9.4 Pfizer Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Corporate Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.10.4 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.10.5 Bristol-Myers Squibb Key News
7.11 Roche
7.11.1 Roche Corporate Summary
7.11.2 Roche Business Overview
7.11.3 Roche Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.11.4 Roche Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.11.5 Roche Key News
7.12 Bettapharma
7.12.1 Bettapharma Corporate Summary
7.12.2 Bettapharma Business Overview
7.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Major Product Offerings
7.12.4 Bettapharma Small Molecule Anti-tumor Targted Drug Revenue in Global Market (2017-2022)
7.12.5 Bettapharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Small Molecule Anti-tumor Targted Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|